Aquestive Therapeutics, Inc. — Director's Dealing 2019

Jun 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2019-06-13

Reporting Person: Cochran John (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-13	Stock Option (Right to Purchase)	$4.38	A	13350	Acquired	2029-06-13	Common Stock (13350)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	75085	Direct

Footnotes

F1: The shares underlying the options vest as follows: 100% of the underlying shares vest June 13, 2020, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date.